Head of Investor Relations
Editas Medicine, Inc. (EDIT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Mark Mullikin is recorded as Head of Investor Relations at Editas Medicine, Inc. (EDIT). Mark Mullikin has spoken on 2 earnings calls across 1 company, most recently for Editas Medicine, Inc. on November 5, 2020.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Recorded roles and call appearances connecting this person to public companies.
Head of Investor Relations
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
